The oncolytic Ad co-expressing IL-23 and p35 elicited potent antitumor effect, correlated with up-regulation of IL-12, IL-23, IFN-γ, and TNF-αwithin the tumor tissues as well as the significant reduction of regulatory T (Treg) cell frequency. This evidence concerns the gene IFNG and neoplasm.